Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. (KMTS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
kmts · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$30.00
Consensus
$28.00
+44.3% upside
Low
$24.00
Median: $29 · Last Close: $19.40
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$28.00
44.3% upside
High Target
$30
54.6%
Low Target
$24
23.7%
Current Price
$19.40
as of today
Based on analyst price targets, the KMTS stock price prediction for the next 12 months ranges from $24 to $30. The consensus KMTS price forecast of $28.00 implies 44.3% upside from the current price of $19.40.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $18.64 | ↓ 3.93% |
1-day model range: $18.48–$18.79. Peak: $18.79 (-3.93%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $15 | -21.2% |
| 2028 | $13 | -30.4% |
| 2029 | $13 | -34.9% |
| 2030 | $12 | -37.2% |
| 2031 | — | -38.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KMTS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-09 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2026-04-07 | BTIG | Maintains | Buy→Buy |
| 2026-03-25 | BTIG | Maintains | Buy→Buy |
| 2026-03-18 | BTIG | Maintains | Buy→Buy |
| 2025-12-15 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-12-12 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-12-12 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-07-17 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-04-16 | Goldman Sachs | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Kestra Medical Technologies, Ltd. (KMTS) stock. Of the recent 9 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover KMTS.
Analyst Recommendation Trends
KMTS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$58M
↓ 56.2% YoY
Revenue Next Year
$93M
↑ 59.6% YoY
EPS This Year
$-2.29
EPS Next Year
$-2.34
↑ 2.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast KMTS EPS of $-2.29 for the current fiscal year, based on estimates from 5 analysts. The KMTS revenue forecast is $58M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KMTS stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KMTS price target is $28.00 (+44.3% upside), with an analyst consensus of Buy.
The KMTS short-term stock prediction for tomorrow is $18.64 (-3.93%). The KMTS stock price prediction for 2027 estimates an average of $15. The KMTS stock prediction for 2030 projects a range of $11–$13.
Kestra Medical Technologies, Ltd. trades on NASDAQ under the ticker KMTS. The KMTS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
KMTS forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month KMTS price target is $28.00, with a high forecast of $30.00 and a low of $24.00. The median price target is shown in the chart above when available. This implies +44.3% potential upside from the current price of $19.40.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.